SERPINF1

serpin family F member 1, the group of Serpin peptidase inhibitors

Basic information

Region (hg38): 17:1762029-1777565

Previous symbols: [ "PEDF" ]

Links

ENSG00000132386NCBI:5176OMIM:172860HGNC:8824Uniprot:P36955AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • osteogenesis imperfecta type 6 (Strong), mode of inheritance: AR
  • osteogenesis imperfecta type 6 (Strong), mode of inheritance: AR
  • osteogenesis imperfecta type 3 (Supportive), mode of inheritance: AD
  • osteogenesis imperfecta type 4 (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Osteogenesis imperfecta, type VIARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal11771667; 17127117; 21353196; 21826736; 22947550; 23613367
Bisphosphonates may reduce fracture frequency, and use of RANKL antibody has been described as potentially beneficial

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SERPINF1 gene.

  • not_provided (253 variants)
  • Osteogenesis_imperfecta_type_6 (77 variants)
  • Inborn_genetic_diseases (57 variants)
  • Osteogenesis_imperfecta (23 variants)
  • SERPINF1-related_disorder (17 variants)
  • not_specified (15 variants)
  • Osteogenesis_imperfecta_type_III (3 variants)
  • Osteogenesis_Imperfecta,_Recessive (3 variants)
  • Osteoporosis (2 variants)
  • Hirschsprung_disease,_susceptibility_to,_1 (1 variants)
  • See_cases (1 variants)
  • Abnormality_of_the_skeletal_system (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERPINF1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002615.7. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
85
clinvar
2
clinvar
91
missense
3
clinvar
121
clinvar
13
clinvar
3
clinvar
140
nonsense
13
clinvar
6
clinvar
19
start loss
1
1
frameshift
17
clinvar
7
clinvar
3
clinvar
27
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
1
clinvar
7
Total 32 21 129 98 5

Highest pathogenic variant AF is 0.000030355444

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SERPINF1protein_codingprotein_codingENST00000254722 715616
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.80e-80.4891257130341257470.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.9112752361.170.00001422714
Missense in Polyphen8880.5071.0931931
Synonymous-2.311361061.290.00000699866
Loss of Function0.9041317.00.7649.51e-7197

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003620.000362
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.000.00
European (Non-Finnish)0.0001580.000158
Middle Eastern0.0002720.000272
South Asian0.00006530.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Neurotrophic protein; induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. As it does not undergo the S (stressed) to R (relaxed) conformational transition characteristic of active serpins, it exhibits no serine protease inhibitory activity. {ECO:0000269|PubMed:7592790, ECO:0000269|PubMed:8226833}.;
Disease
DISEASE: Osteogenesis imperfecta 6 (OI6) [MIM:613982]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI6 is a severe, autosomal recessive form compatible with OI type III in the Sillence classification. {ECO:0000269|PubMed:21353196}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Wnt signaling pathway - Homo sapiens (human);Wnt Signaling Pathway (Consensus)

Intolerance Scores

loftool
0.283
rvis_EVS
-0.6
rvis_percentile_EVS
18.19

Haploinsufficiency Scores

pHI
0.458
hipred
N
hipred_score
0.219
ghis
0.594

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.152

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Serpinf1
Phenotype
reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
kidney development;multicellular organism development;aging;short-term memory;cell population proliferation;response to acidic pH;negative regulation of endothelial cell migration;negative regulation of gene expression;negative regulation of endopeptidase activity;positive regulation of neuron projection development;negative regulation of angiogenesis;ovulation cycle;response to arsenic-containing substance;negative regulation of inflammatory response;positive regulation of neurogenesis;retina development in camera-type eye;negative regulation of epithelial cell proliferation involved in prostate gland development;cellular response to cobalt ion;cellular response to retinoic acid;cellular response to glucose stimulus;cellular response to dexamethasone stimulus;negative regulation of neuron death
Cellular component
extracellular region;basement membrane;extracellular space;melanosome;axon hillock;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome
Molecular function
serine-type endopeptidase inhibitor activity;protein binding